Tanimoto Sarina — SEC Form 4 filings
SEC reporting owner CIK 1951291. 28 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2024-02-28 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 74 legs across 23 filings — 2,053,260 shares, $23,798,897 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 45,124 shares @ $16.76 ($756,296) in ARS Pharmaceuticals, Inc., filed 2024-11-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | CHIEF MEDICAL OFFICER, 10% owner | 28 | — | 74 legs · 2,053,260 sh · $23,798,897 | 18 |
Form 4 filings — Tanimoto Sarina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 240,000 (derivative) @ $0 · Grant/award (A): 875,000 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 12,344 @ $14.03 · Sale (S): 37,656 @ $14.09 | EDGAR |
| 2025-01-03 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 261,900 (derivative) @ $0 · Grant/award (A): 767,600 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $11.67 · Sale (S): 50,000 @ $11.67 | EDGAR |
| 2024-12-11 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $13.17 · Sale (S): 50,000 @ $13.16 | EDGAR |
| 2024-12-09 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 13,789 @ $1.44 · Option exercise (M): 11,876 @ $8.42 · Option exercise (M): 11,876 @ $8.42 · Option exercise (M): 13,789 (derivative) @ $0 · Option exercise (M): 11,876 (derivative) @ $0 · Option exercise (M): 11,876 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $13.95 · Sale (S): 50,000 @ $13.95 | EDGAR |
| 2024-11-14 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 45,045 @ $16.76 · Sale (S): 4,955 @ $17.64 · Sale (S): 45,124 @ $16.76 · Sale (S): 4,876 @ $17.64 | EDGAR |
| 2024-10-17 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 48,550 @ $14.86 · Sale (S): 1,450 @ $15.25 · Sale (S): 50,000 @ $14.88 | EDGAR |
| 2024-10-10 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $13.83 · Sale (S): 50,000 @ $13.83 | EDGAR |
| 2024-09-19 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $12.93 · Sale (S): 50,000 @ $12.93 | EDGAR |
| 2024-09-12 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $11.50 · Sale (S): 50,000 @ $11.50 | EDGAR |
| 2024-08-21 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 35,944 @ $14.76 · Sale (S): 11,756 @ $15.61 · Sale (S): 2,300 @ $16.26 · Sale (S): 36,216 @ $14.76 · Sale (S): 11,523 @ $15.62 · Sale (S): 2,261 @ $16.25 | EDGAR |
| 2024-08-15 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 14,599 @ $11.78 · Sale (S): 35,401 @ $12.76 · Sale (S): 14,637 @ $11.77 · Sale (S): 35,363 @ $12.77 | EDGAR |
| 2024-07-18 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $11.40 · Sale (S): 50,000 @ $11.40 | EDGAR |
| 2024-07-11 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $9.62 · Sale (S): 50,000 @ $9.62 | EDGAR |
| 2024-06-13 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 2,166 @ $9.00 · Sale (S): 1,972 @ $9.00 · Sale (S): 47,834 @ $9.15 · Sale (S): 48,028 @ $9.14 | EDGAR |
| 2024-05-16 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 2,873 @ $9.01 · Sale (S): 2,884 @ $9.01 · Sale (S): 2,381 @ $9.05 · Sale (S): 2,766 @ $9.04 · Sale (S): 44,746 @ $9.06 · Sale (S): 44,350 @ $9.06 | EDGAR |
| 2024-05-09 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $9.34 · Sale (S): 50,000 @ $9.34 | EDGAR |
| 2024-04-24 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 82,733 @ $0.84 · Option exercise (M): 48,260 @ $1.44 · Option exercise (M): 82,733 (derivative) @ $0 · Option exercise (M): 48,260 (derivative) @ $0 | EDGAR |
| 2024-04-22 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 119,047 @ $0.84 · Option exercise (M): 69,444 @ $1.44 · Option exercise (M): 119,047 (derivative) @ $0 · Option exercise (M): 69,444 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $9.28 · Sale (S): 50,000 @ $9.28 | EDGAR |
| 2024-04-10 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 50,000 @ $9.28 · Sale (S): 50,000 @ $9.28 | EDGAR |
| 2024-03-26 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 1,017 @ $9.03 · Sale (S): 1,326 @ $9.01 · Sale (S): 47,635 @ $9.12 · Sale (S): 47,632 @ $9.12 | EDGAR |
| 2024-03-21 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 976 @ $9.03 · Sale (S): 942 @ $9.04 · Sale (S): 372 @ $9 · Sale (S): 100 @ $9 | EDGAR |
| 2024-03-15 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 1,500 @ $9 · Sale (S): 1,300 @ $9 · Sale (S): 205 @ $9 · Sale (S): 239 @ $9 · Sale (S): 48,295 @ $9.14 · Sale (S): 48,461 @ $9.14 | EDGAR |
| 2024-03-01 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 800 @ $9.02 · Sale (S): 1,982 @ $9.01 · Sale (S): 1,000 @ $9.02 | EDGAR |
| 2024-02-28 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 100 @ $9.01 · Sale (S): 500 @ $9.01 · Sale (S): 100 @ $9.01 · Sale (S): 25,456 @ $9.02 · Sale (S): 49,019 @ $9.02 · Sale (S): 24,303 @ $9.02 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951291 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →